Global Orally Disintegrating Tablet Technology Market Growth (Status and Outlook) 2024-2030

Global Orally Disintegrating Tablet Technology Market Growth (Status and Outlook) 2024-2030

Orally disintegrating tablet (ODT) technology involves the formulation of tablets that rapidly disintegrate and dissolve in the mouth without the need for water. This innovative pharmaceutical dosage form is designed to enhance patient convenience and compliance, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs typically utilize superdisintegrants, such as crospovidone or sodium starch glycolate, along with other excipients and processing techniques to promote rapid disintegration upon contact with saliva. The resulting tablet formulation provides a pleasant mouthfeel, quick dissolution, and improved bioavailability of the active pharmaceutical ingredient, making it suitable for various patient populations, including pediatric, geriatric, and psychiatric patients. Additionally, ODT technology offers advantages in terms of dosing accuracy, ease of administration, and potentially faster onset of action compared to conventional oral dosage forms.

The global Orally Disintegrating Tablet Technology market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Orally Disintegrating Tablet Technology Industry Forecast” looks at past sales and reviews total world Orally Disintegrating Tablet Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Orally Disintegrating Tablet Technology sales for 2023 through 2029. With Orally Disintegrating Tablet Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orally Disintegrating Tablet Technology industry.

This Insight Report provides a comprehensive analysis of the global Orally Disintegrating Tablet Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Orally Disintegrating Tablet Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orally Disintegrating Tablet Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orally Disintegrating Tablet Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orally Disintegrating Tablet Technology.

United States market for Orally Disintegrating Tablet Technology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Orally Disintegrating Tablet Technology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Orally Disintegrating Tablet Technology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Orally Disintegrating Tablet Technology players cover Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Lyophilization
Compressed Tablets
Cotton candy Process

Segmentation by Application:
Pharmaceutical
Nutraceuticals
Chewable Vitamin

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Lyophilization
Compressed Tablets
Cotton candy Process

Segmentation by Application:
Pharmaceutical
Nutraceuticals
Chewable Vitamin

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
Roquette
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF
Adare Pharma
Akina
Vitaquest

Please note: The report will take approximately 2 business days to prepare and deliver.